Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

Item

http://www.wikidata.org/entity/Q36579101

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

@ast

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

@en

type

Item

label

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

@ast

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

@en

prefLabel

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

@ast

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

@en

P1476

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

@en

P2093

Adriano Giacomin

http://www.w3.org/2001/XMLSchema#string

Arianna Simonetti

http://www.w3.org/2001/XMLSchema#string

Carmen Martos

http://www.w3.org/2001/XMLSchema#string

Carmen Tereanu

http://www.w3.org/2001/XMLSchema#string

Claudia Allemani

http://www.w3.org/2001/XMLSchema#string

HAEMACARE Working Group

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Lutz

http://www.w3.org/2001/XMLSchema#string

Marc Maynadié

http://www.w3.org/2001/XMLSchema#string

Otto Visser

http://www.w3.org/2001/XMLSchema#string

Riccardo Capocaccia

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

A specialist leukaemia/lymphoma registry in the UK. Part 1: Incidence and geographical distribution of Hodgkin's disease. Leukaemia Research Fund Data Collection Study Group

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

P304

230-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2012.064014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Milena Sant

Rafael Marcos-Gragera

Roberta De Angelis

P577

2012-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230864185

http://www.w3.org/2001/XMLSchema#string

P698

22983589

http://www.w3.org/2001/XMLSchema#string

P932

3561430

http://www.w3.org/2001/XMLSchema#string